Source: 5th Sleep and Breathing Conference
Disease area: Respiratory critical care, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Johan Verbraecken. Too much or too little (ventilation): pathophysiology of central sleep apnoea and hypoventilation (including opioids, treatment-emergent etc.). 5th Sleep and Breathing Conference

Member's Comments

No comment yet.

Related content which might interest you: Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep Source: Eur Respir Rev 2007; 16: 115-124 Year: 2007 Central sleep apnea Source: Respipedia Article Year: 2017 Treatment options for central sleep apnea (including auto-CPAP) Source: Annual Congress 2005 - Central sleep apnoea Year: 2005 CPAP in the elderly with non-severe obstructive sleep apnea: effect on cardiovascular events and somnolence. Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Noninvasive ventilation in sleep apnoea Source: ISSN=1025-448x, ISBN=1-904097-17-0, page=227 Year: 2001 Pathophysiology of central sleep apnea Source: Annual Congress 2005 - Central sleep apnoea Year: 2005 The clinical significance nocturnal hypoventilation (NH) in patients with severe obstructive sleep apnoea (OSA) Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Obstructive sleep apnea Source: Respipedia Article Year: 2017 Long-term effects of noninvasive mechanical ventilation (NMV) in COPD patients with obstructive sleep apnoea (OSA) (overlap syndrome) Source: Eur Respir J 2001; 18: Suppl. 33, 402s Year: 2001 Neural respiratory drive during apnoeic events in obstructive sleep apnoea Source: Eur Respir J 2008; 31: 650-657 Year: 2008 Pathophysiology of OSA Source: Eur Respir Mon 2010; 50: 31-50 Year: 2010 Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA). Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 CPAP to treat obstructive sleep apnoea (OSA) in children with Down syndrome (DS) Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality Year: 2016 Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB) Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Serotonin in obstructive sleep apnea patients with before and after the continuous positive airway pressure treatment Source: Annual Congress 2005 - Upper airway interventions in OSA patients Year: 2005 Apnoeic and obstructive nonapnoeic sleep respiratory events Source: Eur Respir J 2009; 34: 156-161 Year: 2009 Adaptive servo-ventilation (ASV) therapy for sleep disordered breathing (SDB) associated with opioid medications Source: Annual Congress 2007 - Sleep apnoea and adaptive servo–ventilation Year: 2007